AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14678344 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (individualized feedback letters)
Number of subjects: 303
Study 14678344 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 303
Study 14678344 — intervention group
Group type: EXPERIMENTAL
Intervention: Pages providing references to scientific publications or prescribing information
Number of subjects: 303
Study 11752031 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone and cytotoxic agents
Number of subjects: 38
Study 11752031 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose cyclophosphamide then azathioprine
Number of subjects: 38
Study 11752031 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 38
Study 11752031 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunosuppressive treatment
Number of subjects: 38
Study 11752031 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment
Number of subjects: 38
Study 11752031 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunosuppressive therapy
Number of subjects: 38
Study 10662477 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate
Number of subjects: 640
Study 10662477 — intervention group
Group type: COMPARATOR
Intervention: Flunisolide
Number of subjects: 640
Study 7595873 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural tinnitus coping training (TCT)
Number of subjects: 43
Study 7595873 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 43
Study 7595873 — intervention group
Group type: COMPARATOR
Intervention: Self-monitoring control group
Number of subjects: 43
Study 12316339 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined low-dose estrogen and progesterone pills
Number of subjects: 100
Study 12316339 — intervention group
Group type: COMPARATOR
Intervention: Different methods of birth control (control group)
Number of subjects: 100
Study 843794 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose heparin
Number of subjects: 0
Study 843794 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole (alone and in combination with aspirin)
Number of subjects: 0
Study 843794 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen
Number of subjects: 0
Study 29406177 — intervention group
Group type: EXPERIMENTAL
Intervention: Thirst-driven fluid administration (200 ml bolus triggered by participants)
Number of subjects: 16
Study 29406177 — intervention group
Group type: EXPERIMENTAL
Intervention: Thirst-driven fluid administration
Number of subjects: 16
Study 29406177 — intervention group
Group type: COMPARATOR
Intervention: Clinician-directed fluid management (1.25 ml kg‐1 h‐1 with 500 ml bolus)
Number of subjects: 16
Study 27673530 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard information plus access to BRECONDA (intervention)
Number of subjects: 222
Study 27673530 — intervention group
Group type: COMPARATOR
Intervention: Standard online information about breast reconstruction (control)
Number of subjects: 222
Study 24692626 — intervention group
Group type: EXPERIMENTAL
Intervention: Polylevolactic acid screws
Number of subjects: 168
Study 24692626 — intervention group
Group type: COMPARATOR
Intervention: Metallic screws
Number of subjects: 168
Study 23328379 — intervention group
Group type: EXPERIMENTAL
Intervention: CIK via intravenous drop infusion for more than 6 times (study group)
Number of subjects: 95
Study 23328379 — intervention group
Group type: COMPARATOR
Intervention: TACE combined with RFA (control group)
Number of subjects: 95
Study 20193998 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient self-reported regular exercise
Number of subjects: 274
Study 20193998 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient self-reported efforts to lose weight (eating less)
Number of subjects: 274
Study 20193998 — intervention group
Group type: COMPARATOR
Intervention: Physician perception of patient exercise
Number of subjects: 274
Study 20193998 — intervention group
Group type: COMPARATOR
Intervention: Physician perception of patient weight loss efforts
Number of subjects: 274
Study 20193998 — intervention group
Group type: EXPERIMENTAL
Intervention: Kappa score for patient self-reported exercise
Number of subjects: 274
Study 20193998 — intervention group
Group type: EXPERIMENTAL
Intervention: Kappa score for patient self-reported weight loss efforts
Number of subjects: 274
Study 20193998 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese patients reporting weight loss efforts or regular exercise
Number of subjects: 274
Study 20193998 — intervention group
Group type: COMPARATOR
Intervention: Physician perception of obese patients' activities
Number of subjects: 274
Study 18611068 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-adhesion molecule therapy; specific agents not mentioned
Number of subjects: 0
Study 18611068 — intervention group
Group type: COMPARATOR
Intervention: Anti-TNF therapy (infliximab, adalimumab)
Number of subjects: 0
Study 16025962 — intervention group
Group type: EXPERIMENTAL
Intervention: Puerarin injection (PI)
Number of subjects: 100
Study 16025962 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose‐1,6‐disphosphate (FDP)
Number of subjects: 100
Study 16025962 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 100
Study 11432713 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamins/mineral and garlic preparation
Number of subjects: 0
Study 11432713 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study 9683123 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrocautery (n = 42)
Number of subjects: 74
Study 9683123 — intervention group
Group type: COMPARATOR
Intervention: Scalpel (n = 38)
Number of subjects: 74
Study 9683123 — intervention group
Group type: EXPERIMENTAL
Intervention: Jackson‐Pratt drains
Number of subjects: 74
Study 9683123 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower estimated blood loss
Number of subjects: 74
Study 7811509 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% + epinephrine 1:200,000 infiltration
Number of subjects: 50
Study 7811509 — intervention group
Group type: COMPARATOR
Intervention: Normal saline infiltration
Number of subjects: 50
Study 2907349 — intervention group
Group type: EXPERIMENTAL
Intervention: bopindolol, 1 mg once daily for 1 week
Number of subjects: 10
Study 2907349 — intervention group
Group type: EXPERIMENTAL
Intervention: atenolol, 50 mg once daily for 1 week
Number of subjects: 10
Study 2907349 — intervention group
Group type: COMPARATOR
Intervention: adrenaline infusion (20 ng/kg per min)
Number of subjects: 10
Study 1929842 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol (50 mg per rectum, four times per day)
Number of subjects: 66
Study 1929842 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimethyl sulfoxide (500 mg per rectum, four times per day)
Number of subjects: 66
Study 1929842 — intervention group
Group type: COMPARATOR
Intervention: Control (no radical scavengers, only analgesic regimen)
Number of subjects: 66
Study 1929842 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol or Dimethyl sulfoxide
Number of subjects: 66
Study 324238 — intervention group
Group type: EXPERIMENTAL
Intervention: G 31.406
Number of subjects: 118
Study 324238 — intervention group
Group type: EXPERIMENTAL
Intervention: Orphenadrine
Number of subjects: 118
Study 324238 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study 30767563 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic procedure for inguinal hernia (IH) after RARP
Number of subjects: 148
Study 30767563 — intervention group
Group type: COMPARATOR
Intervention: No prophylactic procedure (control)
Number of subjects: 148
Study 30767563 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic procedure for IH
Number of subjects: 148
Study 28032413 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic animations
Number of subjects: 167
Study 28032413 — intervention group
Group type: COMPARATOR
Intervention: Static images
Number of subjects: 167
Study 26039019 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular physical activity (PA)
Number of subjects: 62
Study 26039019 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular physical activity (PA) and vitamin C supplementation (C)
Number of subjects: 62
Study 26039019 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy individuals without MS)
Number of subjects: 62
Study 22763493 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation strategy (multifaceted training programme)
Number of subjects: 40
Study 22763493 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study 22763493 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation strategy
Number of subjects: 40
Study 22763493 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 21375731 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooperation mechanism between local CDCs and university hospitals (intervention group)
Number of subjects: 0
Study 21375731 — intervention group
Group type: COMPARATOR
Intervention: Standard care without cooperation mechanism (control group)
Number of subjects: 0
Study 21141016 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Small-Incision Cataract Surgery (MSICS)
Number of subjects: 88
Study 21141016 — intervention group
Group type: COMPARATOR
Intervention: Conventional Extracapsular Cataract Extraction with PCIOL (ECCE with PCIOL)
Number of subjects: 88
Study 17194863 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention (10-15 minute counseling sessions by a nutritionist)
Number of subjects: 255
Study 17194863 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention
Number of subjects: 255
Study 17194863 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only condition
Number of subjects: 255
Study 15047679 — intervention group
Group type: EXPERIMENTAL
Intervention: 19% fat diet
Number of subjects: 11
Study 15047679 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% fat diet
Number of subjects: 11
Study 15047679 — intervention group
Group type: COMPARATOR
Intervention: 30% fat diet (control)
Number of subjects: 11
Study 11255420 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity (walking)
Number of subjects: 39372
Study 11255420 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking pace
Number of subjects: 39372
Study 11255420 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity (general)
Number of subjects: 39372
Study 9676837 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral 13‐cis‐retinoic acid at a dose of 1 mg/kg
Number of subjects: 147
Study 9676837 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5‐4 microM concentrations of 13‐cis‐retinoic acid
Number of subjects: 147
Study 9676837 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 147
Study 7740961 — intervention group
Group type: EXPERIMENTAL
Intervention: Timopentina (50 mg/3 times per week for 6 weeks, 4 or 5 cycles during the year)
Number of subjects: 25
Study 7740961 — intervention group
Group type: COMPARATOR
Intervention: Control group (no timopentina)
Number of subjects: 25
Study 2691169 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental dental rinse (15 ml, rinsed for 30 seconds)
Number of subjects: 0
Study 2691169 — intervention group
Group type: COMPARATOR
Intervention: Placebo rinse
Number of subjects: 0
Study 2691169 — intervention group
Group type: COMPARATOR
Intervention: Conventional mouthwash
Number of subjects: 0
Study 5332751 — intervention group
Group type: EXPERIMENTAL
Intervention: Analgesic-sedative combination (Fiorinal-C(1/4))
Number of subjects: 90
Study 5332751 — intervention group
Group type: EXPERIMENTAL
Intervention: Analgesic (APC-C)
Number of subjects: 90
Study 5332751 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 31899315 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-FU + mBYD
Number of subjects: 615
Study 31899315 — intervention group
Group type: EXPERIMENTAL
Intervention: mBYD
Number of subjects: 615
Study 30238401 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 0
Study 30238401 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 0
Study 30238401 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 0
Study 30238401 — intervention group
Group type: EXPERIMENTAL
Intervention: Avelumab
Number of subjects: 0
Study 30238401 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab
Number of subjects: 0
Study 30238401 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0
Study 27138893 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based Cognitive Behavioural Therapy (CBT)
Number of subjects: 0
Study 27138893 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 25539586 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftaroline fosamil (600 mg every 12 h)
Number of subjects: 847
Study 25539586 — intervention group
Group type: COMPARATOR
Intervention: Ceftriaxone (2 g every 24 h)
Number of subjects: 847
Study 25539586 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftaroline fosamil
Number of subjects: 847
Study 25539586 — intervention group
Group type: COMPARATOR
Intervention: Ceftaroline fosamil and Ceftriaxone
Number of subjects: 847
Study 23906491 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based eccentric training program based on the Alfredson protocol (straight leg and bent knee heel drops and raises)
Number of subjects: 20
Study 23906491 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based eccentric training program based on the Alfredson protocol
Number of subjects: 20
Study 23906491 — intervention group
Group type: COMPARATOR
Intervention: Control group (subjects without lower extremity pain)
Number of subjects: 20
Study 21571593 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg fingolimod
Number of subjects: 1027
Study 21571593 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.25 mg fingolimod
Number of subjects: 1027
Study 21571593 — intervention group
Group type: COMPARATOR
Intervention: Interferon beta‐1a to 0.5 mg fingolimod
Number of subjects: 1027
Study 21571593 — intervention group
Group type: COMPARATOR
Intervention: Interferon beta‐1a to 1.25 mg fingolimod
Number of subjects: 1027
Study 19124845 — intervention group
Group type: EXPERIMENTAL
Intervention: N(G)-monomethyl-L-arginine (L-NMMA)
Number of subjects: 3
Study 19124845 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine
Number of subjects: 3
Study 19124845 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study 16716322 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 2 embryo transfer
Number of subjects: 281
Study 16716322 — intervention group
Group type: COMPARATOR
Intervention: Day 3 embryo transfer
Number of subjects: 281
Study 15057570 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of a prosthetic valve (PV)
Number of subjects: 41
Study 15057570 — intervention group
Group type: EXPERIMENTAL
Intervention: Infection with Enterococcus faecalis
Number of subjects: 41
Study 15057570 — intervention group
Group type: COMPARATOR
Intervention: Age, gender, race, polymicrobial infection, community-acquired infection
Number of subjects: 41
Study 11890582 — intervention group
Group type: EXPERIMENTAL
Intervention: Home hazard assessment, information on hazard reduction, and installation of safety devices (n = 570)
Number of subjects: 1737
Study 11890582 — intervention group
Group type: COMPARATOR
Intervention: No safety devices or information on home hazard reduction (n = 1,167)
Number of subjects: 1737
Study 9457525 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent follow-up
Number of subjects: 597
Study 9457525 — intervention group
Group type: COMPARATOR
Intervention: Control group with follow-up every 5 years
Number of subjects: 597
Study 8162725 — intervention group
Group type: EXPERIMENTAL
Intervention: High flow transtracheal oxygen (HFTTO)
Number of subjects: 10
Study 8162725 — intervention group
Group type: EXPERIMENTAL
Intervention: High flow nasal prongs (HFNP)
Number of subjects: 10
Study 8162725 — intervention group
Group type: COMPARATOR
Intervention: Low flow transtracheal oxygen (LFTTO)
Number of subjects: 10
Study 17171925 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose fentanyl (75 microg/kg followed by 0.3 microg/kg/min)
Number of subjects: 40
Study 17171925 — intervention group
Group type: COMPARATOR
Intervention: Diazepam-ketamine (0.8 mg/kg D and 2 mg/kg K followed by 0.07 mg/kg/h D and 1 mg/kg/h K)
Number of subjects: 40
Study 31451920 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model for readmission for dehydration after DLI creation
Number of subjects: 25638
Study 30514262 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg/day)
Number of subjects: 160
Study 30514262 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (850 mg bis in die)
Number of subjects: 160
Study 30514262 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of aspirin and metformin
Number of subjects: 160
Study 30514262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 30514262 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin and Metformin
Number of subjects: 160
Study 27253336 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated Learning Environments (SLE) - two 3-hour workshops with simulated clinical teaching scenarios and facilitated debrief.
Number of subjects: 18
Study 27253336 — intervention group
Group type: COMPARATOR
Intervention: Standard Education (StEd) - two online learning modules.
Number of subjects: 18
Study 24022570 — intervention group
Group type: EXPERIMENTAL
Intervention: HighCHO diet (70% carbohydrate, 20% fat, 10% protein)
Number of subjects: 15
Study 24022570 — intervention group
Group type: COMPARATOR
Intervention: ModCHO diet (45% carbohydrate, 45% fat, 10% protein)
Number of subjects: 15
Study 24022570 — intervention group
Group type: COMPARATOR
Intervention: HighCHO diet
Number of subjects: 15
Study 24022570 — intervention group
Group type: COMPARATOR
Intervention: LowCHO diet (70% fat, 20% carbohydrate, 10% protein)
Number of subjects: 15
Study 23147172 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 1478
Study 23147172 — intervention group
Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 1478
Study 23147172 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertensive participants
Number of subjects: 1478
Study 20922480 — intervention group
Group type: EXPERIMENTAL
Intervention: Workload score based on the number of drugs involved, type of literature search performed, and judgmental categorization.
Number of subjects: 20
Study 20922480 — intervention group
Group type: EXPERIMENTAL
Intervention: Type of literature search performed.
Number of subjects: 20
Study 20922480 — intervention group
Group type: EXPERIMENTAL
Intervention: Categorization of queries as judgmental or not.
Number of subjects: 20
Study 20922480 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of drugs involved.
Number of subjects: 20
Study 19076571 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral decubitus, knee-chest position with a 45 degree head up tilt (group II, n = 90)
Number of subjects: 180
Study 19076571 — intervention group
Group type: COMPARATOR
Intervention: Standard lateral decubitus, knee-chest position (group I, n = 90)
Number of subjects: 180
Study 16398601 — intervention group
Group type: EXPERIMENTAL
Intervention: T'ai Chi (TC)
Number of subjects: 38
Study 16398601 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (EX)
Number of subjects: 38
Study 16398601 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 38
Study 12433892 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous hyperventilation
Number of subjects: 51
Study 12433892 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 age matched controls)
Number of subjects: 51
Study 10029561 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol, 12 microg once daily
Number of subjects: 38
Study 10029561 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol, 6 microg twice daily
Number of subjects: 38
Study 10029561 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol, 24 microg twice daily
Number of subjects: 38
Study 10029561 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline, 500 microg four times daily
Number of subjects: 38
Study 10029561 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower doses of formoterol (12 microg once daily or 6 microg twice daily)
Number of subjects: 38
Study 10029561 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments pooled
Number of subjects: 38
Study 7479225 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (0.1 mg/kg) and atropine (0.02 mg/kg)
Number of subjects: 20
Study 7479225 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 20
Study 2111697 — intervention group
Group type: EXPERIMENTAL
Intervention: rTPA
Number of subjects: 36
Study 2111697 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 7192511 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone, 10 mg
Number of subjects: 10
Study 7192511 — intervention group
Group type: COMPARATOR
Intervention: Atropine, 0.6 mg
Number of subjects: 10
Study 7192511 — intervention group
Group type: COMPARATOR
Intervention: Atropine after Domperidone
Number of subjects: 10
Study 31999753 — intervention group
Group type: EXPERIMENTAL
Intervention: ART during postpartum (PP‐only)
Number of subjects: 4627
Study 31999753 — intervention group
Group type: COMPARATOR
Intervention: AP‐only (ART use limited to the antepartum period)
Number of subjects: 4627
Study 31999753 — intervention group
Group type: COMPARATOR
Intervention: No ART during postpartum (PP‐only)
Number of subjects: 4627
Study 31487627 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 74
Study 31487627 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 74
Study 31487627 — intervention group
Group type: COMPARATOR
Intervention: Alternative treatment
Number of subjects: 74
Study 27689735 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg
Number of subjects: 684
Study 27689735 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 2 mg
Number of subjects: 684
Study 27689735 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib (4 mg)
Number of subjects: 684
Study 27689735 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 684